For Practitioners, Coaches, and Clinicians
Consultation-ready DNA metabolic priorities
- Practitioner summary
- Client-facing pathway explanations
- Biomarkers to validate
- Gene, SNP, and study evidence trail
A pathway-based DNA interpretation report that ranks your metabolic priorities, explains the biology in plain language, shows the SNP/gene evidence, and suggests biomarkers for follow-up.
Launch price: €149
Regular price: €299
Money-back guarantee
DNA is not diagnosis. This report turns genetic signals into testable metabolic hypotheses.
Supports raw DNA files from MyHeritage, 23andMe, AncestryDNA, and other SNP CSV exports.
The same evidence engine can be reviewed as a practitioner workflow asset or as a personal metabolic validation plan.
For Practitioners, Coaches, and Clinicians
For Individuals
The report starts with practical pathway meanings, then lets you inspect the evidence behind them.
The DNA Metabolic Action Report turns raw genetic data into a report you can read first and audit when needed.
A ranked list of metabolic systems where your DNA shows the strongest signal.
For each pathway, you get what the system does and what your result may point to.
You can inspect the genes, SNPs, claims, and study-level evidence behind each score.
Suggested blood markers or observations help confirm whether the DNA signal matters.
Upload a raw DNA export from 23andMe, AncestryDNA, or another SNP CSV provider.
Your matched variants are checked against curated gene, SNP, claim, and study evidence.
Evidence-backed gene signals are grouped into pathway-level priorities.
The report highlights the systems most worth validating first.
You receive a structured PDF report within about 7 days, including explanations, validation markers, and practical next-step guidance.
This report is useful when you want your raw DNA file translated into cautious metabolic follow-up priorities.
You want to understand what it may suggest beyond isolated SNP facts.
Energy, recovery, blood sugar, inflammation, lipids, and longevity are relevant.
The report helps decide which markers and real-world patterns to check first.
The report is evidence-aware and avoids turning DNA into supplement hype.
This report is built for prioritization and follow-up, not for every use case.
This report does not diagnose disease and does not replace clinical assessment.
This report focuses on prioritized interpretation and follow-up markers.
The best use case is someone willing to follow up with biomarkers, symptoms, nutrition, or lifestyle context.
The sample report shows the full flow: pathway score, plain-language explanation, genes/SNP evidence, and validation markers.
The report uses pathway-level interpretation, not deterministic prediction.
Genetic variants can affect enzymes, transporters, receptors, and regulatory systems. A single SNP rarely tells the whole story, so the report aggregates matched evidence across genes and pathways.
The output should be treated as a structured hypothesis: this pathway may deserve follow-up.
It should not be read as: this pathway is definitely impaired.
Read the research summary →Knowledge Base
Use the Knowledge Base when you want to go deeper into pathway pages, gene guides, and related validation markers.
Quick answers before you order.
Regular price €299
Launch price €149
This report does not diagnose disease, predict medical outcomes, or replace professional medical advice.